ArticleDiabetes technology & therapeutics2023
Real-World Glycemic Outcomes with Early Omnipod 5 Use in Youth with Type 1 Diabetes.
Registry-linked trialOpen access · greenAbstract read
In one paragraph
Article in Diabetes technology & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07425912 (Real-World Efficacy and Safety of the TouchCare Nano Automated Insulin Delivery System With APGO Algorithm in Children and Adolescents With Type 1 Diabetes), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Real-World Efficacy and Safety of the TouchCare Nano Automated Insulin Delivery System With APGO Algorithm in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Real-World Evidence of Automated Insulin Delivery System Use.Diabetes technology & therapeutics · 2024Pooled it
- Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12-Month Extension of a Randomized Controlled Trial.Endocrinology, diabetes & metabolism · 2026Trial
- Trial
- Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems.Journal of managed care & specialty pharmacy · 2026Article
- Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study.Diabetes, obesity & metabolism · 2026Observational
- Artificial Pancreas and Closed-Loop Insulin Delivery: From Early Concepts to AI-Driven Diabetes Automation.Biosensors · 2026Review
- Caregiver and Patient Experiences With the Diabetes Care Team Impact Utilization of Medical Nutrition Therapy in Pediatric Type 1 Diabetes.The science of diabetes self-management and care · 2026Article
- Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.Diabetes technology & therapeutics · 2026Article
- Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care.Journal of diabetes science and technology · 2026Article
- Ketone Management in Pediatric Diabetes Centers in the USA: Current Practices and a Call for Improved Standardization.Hormone research in paediatrics · 2026Article
- Safety and Glycemic Outcomes Among Youth With New-Onset Type 1 Diabetes Using a Tubeless Automated Insulin Delivery System.Journal of diabetes research · 2026Observational
- Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025Article
- Changes in 90-Day Time in Range Among Youth With Type 1 Diabetes Initiating Different Automated Insulin Delivery Systems.The Journal of clinical endocrinology and metabolism · 2025Article
- The Effect of Omnipod 5 Automated Insulin Delivery on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.Diabetes technology & therapeutics · 2025Article
- A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025Review
- Artificial Pancreas: The First 20 Years.Journal of diabetes science and technology · 2025Article
- Does the OP5 Automated Insulin Delivery System Close the Gap in Glycemic Control Between White and Black Youth with Type 1 Diabetes?Diabetes technology & therapeutics · 2025Article
- Safety, efficacy and psychological impact of Omnipod hybrid closed loop system in children, adolescents, and adults in 24 h and nighttime: Systematic review with additional meta-analysis.Journal of diabetes and metabolic disorders · 2025Review
- Racial Disparities in the Use of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- Sociodemographic inequities and use of hybrid closed-loop systems associated with obesity in youth with type 1 diabetes.Diabetes research and clinical practice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Brynn E MarksDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-4849-9774
Seema MeighanDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Anum ZehraDivision of Endocrinology and Diabetes, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Julia L DouvasDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0009-0001-7591-7193
Andrew RearsonDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Reshma SureshDivision of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Elizabeth A BrownDivision of Endocrinology and Diabetes, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Risa M WolfDivision of Endocrinology and Diabetes, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-7674-520X
Children's Hospital of Philadelphia · USJohns Hopkins University · US
Funding
Autonomous AI to mitigate disparities for diabetic retinopathy screening in youth during and after COVID-19R01EY033233 · NEI · JOHNS HOPKINS UNIVERSITY · PI WOLF, RISA MICHELLE · 2021 to 2023
$1.9MImplementation of a diabetes navIgator to Mitigate disPArities and improve CGM upTake and sustained use across the lifespan of T1D (IMPACT T1D)R01DK134955 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MATHIOUDAKIS, NESTORAS N, WOLF, RISA MICHELLE · 2022 to 2025
$1.8MDeveloping a patient-centered psychoeducational tool to realize the potential of diabetes technologiesK23DK129827 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI MARKS, BRYNN E · 2022 to 2025
$842kNEI NIH HHS R01 EY033233NIDDK NIH HHS K23 DK129827NIDDK NIH HHS R01 DK134955
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1AdolescentBlood GlucoseBlood Glucose Self-MonitoringChildGlycated HemoglobinHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinAutomated insulin deliveryBarriersGlycemic controlInequitiesMinority youthType 1 diabetes
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT07425912ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.